The transcription of IGF-1 enables the activation of the STAT3 pathway, which enhances the invasive ability of tumor cells in prostate cancer (Ma et al., 2020); Wang et al. (2020) demonstrated that IGF-1 activates NFkB signaling inflammation via cytosolic ROS in various cell cultures. Here, IGF1 is linked to prostate carcinoma.